Based on our results, we speculate that reducing plasma levels of Z-AAT polymers in ZZ-AATD patients using the siRNA strategy may reduce liver damage, but it remains unclear whether or not this will also help to lower the progression of pulmonary emphysema [33]. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.